Catalyst Wire Dossier Catalyst Wire Dossier

P-GEMOX regimen

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for P-GEMOX regimen, covering 2018-05-09 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Sintilimab With P-GEMOX Versus the P-GEMOX in the Teatment of Advanced-stage Extranodal Natural Killer/T Cell Lymphoma [Phase 2]

See pricing